PHYSIOMICS PLC (PYC) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the PHYSIOMICS PLC interim results investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be dismissed at any time by the q and a tab situated at the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives in the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to doctor Peter Sargent, CEO. Good afternoon to you, sir. Thank you. Hi all, and thank you for joining our investor update presentation today. So as I I think most of you will know, my name is Peter Sargent. I'm the new CEO here at, PHYSIOMICS. I'm also joined here today by Doctor. Jim Millan, who will be taking part in, the Q and A session towards the end of the meeting. So today I'd like to provide a quick overview of business for PHYSIOMICS for those of you who are less familiar with what we do here. I'll then like to touch upon our interim results, and provide you some progress as to how we're getting on in the second half, before finishing off with providing you some more information around our strategy going forward. So for those of you who are less familiar with PHYSIOMICS, the business is primarily a consultancy company based here in The UK, just South of Oxford, and we provide mathematical modelling and data science, services to biopharma in support of, their drug development efforts. I'll go into a bit more detail, as to how we support these companies through our core service offering, but ultimately the business has been ...